Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy., PMID:40240911
Development and Characterization of the [177Lu]Lu-Labeled Anti-CDH17 Nanobody Derivative for Radioimmunotherapy in the Gastric Cancer Xenograft Model., PMID:40088168
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity., PMID:39762718
Variability in morphology and immunohistochemistry of Crohn's disease-associated small bowel neoplasms: implications of Claudin 18 and Cadherin 17 expression for tumor-targeted immunotherapies., PMID:39164422
Nanobody-Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING-Mediated Anti-Tumor Immunity., PMID:38888519
Cadherin-17 as a target for the immunoPET of adenocarcinoma., PMID:38625402
Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors., PMID:38452580
The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer., PMID:36744385
CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin., PMID:36435809
A proximity labeling method for protein-protein interactions on cell membrane., PMID:35685794
Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study., PMID:34036629
CDH6-activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers., PMID:33715292
Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist., PMID:33037135
Cadherin-17 Targeted Near-Infrared Photoimmunotherapy for Treatment of Gastrointestinal Cancer., PMID:32931292
The Diagnostic Value of Cadherin 17 and CDX2 Expression as Immunohistochemical Markers in Colorectal Adenocarcinoma., PMID:32929682
Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis., PMID:32873881
64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time., PMID:32371673
111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis., PMID:31605356
Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis., PMID:31324051
Simultaneous amperometric immunosensing of the metastasis-related biomarkers IL-13Rα2 and CDH-17 by using grafted screen-printed electrodes and a composite prepared from quantum dots and carbon nanotubes for signal amplification., PMID:31183566
Determination of Cadherin-17 in Tumor Tissues of Different Metastatic Grade Using a Single Incubation-Step Amperometric Immunosensor., PMID:30134108
RGD cadherins and α2β1 integrin in cancer metastasis: A dangerous liaison., PMID:29673969
Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17., PMID:29474162
Targeting CDH17 in Cancer: When Blocking the Ligand Beats Blocking the Receptor?, PMID:29084915
Monoclonal Antibodies Directed against Cadherin RGD Exhibit Therapeutic Activity against Melanoma and Colorectal Cancer Metastasis., PMID:28916526
CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2., PMID:28029907
Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma., PMID:27846146
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer., PMID:27771609
BILL-cadherin/cadherin-17 contributes to the survival of memory B cells., PMID:25612318
Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer., PMID:24465527
Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma., PMID:24039755
Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis., PMID:23053896
The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer., PMID:22009269
Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA., PMID:20393816
[Effect of monoclonal antibodies against LI-cadherin on the proliferation of human hepatocellular carcinoma cells]., PMID:19460698
Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis., PMID:17589897
Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells., PMID:16361315
Lymphocyte-expressed BILL-cadherin/cadherin-17 contributes to the development of B cells at two stages., PMID:15688343
Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma., PMID:15279905
Ksp-cadherin is a functional cell-cell adhesion molecule related to LI-cadherin., PMID:15023525
Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas., PMID:12824888
LI-cadherin: a marker of gastric metaplasia and neoplasia., PMID:11413113
LI-cadherin gene expression during mouse intestinal development., PMID:11376485
The identification of a nonclassical cadherin expressed during B cell development and its interaction with surrogate light chain., PMID:10906147
Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction., PMID:9755888
Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney., PMID:8531138
Association of intestinal peptide transport with a protein related to the cadherin superfamily., PMID:8153632
For research use only. Not for human or drug use.
